Indication

Gonococcal endocarditis

Gonococcal endocarditis is a severe, life-threatening form of infective endocarditis resulting from the hematogenous dissemination of the Gram-negative diplococcus *Neisseria gonorrhoeae*. Read more about Gonococcal endocarditis

32 drugs 28 manufacturers

Advertisement

Drugs that treat it

Common Gonococcal endocarditis therapies.

Showing 28–32 of 32 drugs

Filter & compare in the drug finder →Opens the drug finder with Gonococcal endocarditis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Gonococcal endocarditis.

Gonococcal endocarditis is a severe, life-threatening form of infective endocarditis resulting from the hematogenous dissemination of the Gram-negative diplococcus *Neisseria gonorrhoeae*.

It is an uncommon manifestation of disseminated gonococcal infection that primarily affects the cardiovascular system, typically occurring in sexually active young adults without preexisting valvular heart disease.

Pathophysiologically, the infection has a marked predilection for native left-sided heart valves—most frequently the aortic valve—and is characterized by an aggressive, destructive clinical course.

Hallmark features include the rapid formation of large valvular vegetations, perivalvular ring abscesses, acute valvular regurgitation, fulminant congestive heart failure, and systemic embolic events.

Personalize your experience

Follow Gonococcal endocarditis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it